comparemela.com

English National Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NICE Endorses Cabozantinib Plus Nivolumab in Advanced RCC

Lack of clarity on use of puberty-blockers for gender dysphoria treatment in Ireland

Lack of clarity on use of puberty-blockers for gender dysphoria treatment in Ireland UK rulings have resulted in a major report and new safeguards, but responses on the issue are not forthcoming in this jurisdiction Mon, May 3, 2021, 06:01   The debate in the UK about the use of puberty-blockers, an experimental treatment administered to children suffering from gender dysphoria, has in recent months seen major rulings in the London high court, a significant report from the health service, and the introduction of a new safeguard for those receiving the treatment. By contrast, in this jurisdiction it is difficult to get anyone to comment on puberty blockers and difficult to establish what responses, if any, are occurring to events on the other side of the Irish Sea.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.